Seasoned private equity and operating executive with experience across buyouts, growth investing and real assets; Edmund Wellington III built a profile advising institutional allocators and serving on portfolio company boards. They focus on operational improvement, capital structuring and exit planning for middle-market companies, with sector emphasis on industrials and business services. Known for sourcing sponsor-backed deals and leading value-creation initiatives, they are a frequent interlocutor for limited partners and strategic acquirers.
Seasoned private equity and operating executive with experience across buyouts, growth investing and real assets; Edmund Wellington III built a profile advising institutional allocators and serving on portfolio company boards. They focus on operational improvement, capital structuring and exit planning for middle-market companies, with sector emphasis on industrials and business services. Known for sourcing sponsor-backed deals and leading value-creation initiatives, they are a frequent interlocutor for limited partners and strategic acquirers.
Centers on middle‑market control and growth investments across industrials, business services and real assets, deploying operational playbooks to accelerate margin expansion and organic growth. Prefers sponsor-backed and co-invest opportunities where capital structuring, hands-on board governance and staged value-creation milestones reduce execution risk. Employs a multi‑year horizon, metrics-driven diligence and conservatively levered deals to balance upside with downside protection, positioning for strategic sales or private-market exits.
Centers on middle‑market control and growth investments across industrials, business services and real assets, deploying operational playbooks to accelerate margin expansion and organic growth. Prefers sponsor-backed and co-invest opportunities where capital structuring, hands-on board governance and staged value-creation milestones reduce execution risk. Employs a multi‑year horizon, metrics-driven diligence and conservatively levered deals to balance upside with downside protection, positioning for strategic sales or private-market exits.
| Trades 81 | Longs Won 62/81 76% | Profit Factor 10.93 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $650,914.84 |
| Average Win $342,496.74 | Best Trade (Aug 02) $6.35M | Sharpe Ratio -416.67 |
| Average Loss -$102,231.2 | Worst Trade (Aug 02) -$653,375.03 | Z-Score 10.14 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 3d | Expectancy $238,177.84 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 880 | 792 | 704 | 616 | 528 | 440 | 352 | 264 | 176 | 88 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2,339 | $479,892.63 | $722,540.49 | - | $242,647.86 | 50.56% | -7.354% |
ABBV AbbVie Inc. | 3,853 | $715,193.86 | $966,871.82 | - | $251,677.96 | 35.19% | -2.513% |
ABT Abbott Laboratories | 4,208 | $572,330.08 | $444,785.6 | - | -$127,544.48 | -22.29% | +0.085% |
AMAT Applied Materials, Inc. | 1,900 | $347,833 | $964,573.02 | - | $616,740.02 | 177.31% | +1.176% |
AME Ametek Inc. | 2,000 | $361,920.02 | $483,420.02 | - | $121,500 | 33.57% | +0.708% |
AMGN Amgen Inc. | 2,870 | $801,332.7 | $1.11M | - | $304,076.5 | 37.95% | -0.64% |
AMZN Amazon.com Inc | 2,390 | $524,342.1 | $649,076.18 | - | $124,734.08 | 23.79% | +15.321% |
AVGO Broadcom Inc. | 839 | $231,270.35 | $326,605.92 | - | $95,335.57 | 41.22% | +0.371% |
BABA Alibaba Group Holding Limited SP ADR | 3,405 | $386,161.05 | $416,261.25 | - | $30,100.2 | 7.79% | +5.098% |
BSV Vanguard Short-Term Bond ETF | 9,813 | $772,283.1 | $761,292.54 | - | -$10,990.56 | -1.42% | -0.077% |
CAH Cardinal Health Inc. | 8,000 | $1.34M | $1.84M | - | $496,239.99 | 36.92% | +1.304% |
CAKE The Cheesecake Factory Incorporated | 18,600 | $1.17M | $1.89M | - | $720,936 | 61.86% | +0.109% |
CGDV Capital Group Dividend Value ETF | 9,942 | $392,609.58 | $492,526.68 | - | $99,917.1 | 25.45% | +0.63% |
CGGR Capital Group Growth ETF | 17,451 | $709,383.15 | $782,677.35 | - | $73,294.2 | 10.33% | +0.651% |
CGMS Capital Group U.S. Multi-Sector Income ETF | 74,041 | $2.05M | $2M | - | -$45,905.42 | -2.24% | -0.699% |
CGUS Capital Group Core Equity ETF | 7,201 | $265,932.93 | $321,812.69 | - | $55,879.76 | 21.01% | +1.292% |
CRM Salesforce Inc | 799 | $217,879.31 | $147,031.98 | - | -$70,847.33 | -32.52% | +1.832% |
CSCO Cisco Systems, Inc. | 42,115 | $2.92M | $4.88M | - | $1.96M | 67.18% | +2.14% |
CVS CVS Health Corporation | 7,198 | $496,518.04 | $751,687.14 | - | $255,169.1 | 51.39% | -0.751% |
CVX Chevron Corporation | 4,917 | $704,065.23 | $967,813.11 | - | $263,747.88 | 37.46% | +2.35% |